We use cookies to ensure that we give you the best experience on our website Learn more

Jun 22, 2018

IUSTI 2018 World +European Congress

02 / HUMAN PAPILLOMAVIRUS VACCINE UPTAKE AMONG YOUNG GAY AND BISEXUAL MEN WHO HAVE SEX WITH MEN WITH A TARGETED PROGRAMME THROUGH SEXUAL HEALTH SERVICES IN MELBOURNE, AUSTRALIA

hpv

human papillomavirus

vaccine

vaccination

wart

genital wart

coverage

uptake

gay

men who have sex with men

australia

melbourne

Abstract

Abstract

thumbnail

Keywords

hpv

human papillomavirus

vaccine

vaccination

wart

genital wart

coverage

uptake

gay

men who have sex with men

australia

melbourne

Abstract

Background: In mid-2017, the Victorian Government funded a free human papillomavirus (HPV) vaccination catch-up programme for men who have sex with men (MSM) aged up to 26 years through sexual health clinics or other immunisation centres. We aimed to examine the uptake of the HPV vaccine among young MSM attending the Melbourne Sexual Health Clinic (MSHC). Methods: MSM aged ≤26 attending MSHC between 27-April-2017 and 31-December-2017 were included in the analysis. HPV vaccine uptake was calculated based on the first consultation of each client during the period. Multivariable logistic regression was performed to examine the association between vaccine uptake and client factors. Results: There were 2108 MSM aged ≤26 attended MSHC over the study period with 7.6% (n=161) reporting previous HPV vaccination. Of the 1947 eligible men, 1134 (58.2%, 95% CI: 56.0% to 60.4%) were offered the vaccine, and 830 (42.6%, 95% CI: 40.4% to 44.9%) received it on the day. Men with a history of genital warts (adjusted odds ratio [aOR]=3.12, 95% CI: 1.39 to 7.00) and those who had >4 male partners in last 12 months (aOR=1.38, 95% CI: 1.04 to 1.85) were more likely to receive the HPV vaccine on the day. There were 304 MSM declined the vaccine, most men did not specify the reason (31.3%, n=95) and 27.3% needed time to think (n=83). Conclusions: Although vaccine uptake was 73.2% among those offered, the actual coverage in those eligible remained unsatisfactory (42.1%) in a sexual health clinic. This highlights a clinic-based targeted MSM programme may not reach sufficiently high vaccine coverage to provide MSM with the same vaccine benefits as heterosexuals.

Discover over 20,000 new abstracts, posters and presentations from leading academic conferences every month. Stay on top of the latest findings, methodologies and discussions happening in your research field around the world.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.